CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, is excited to announce ...

Imatinib oral solution has gained FDA approval for the treatment of some cancers, including certain forms of leukemia.

Currently, treatment options for glioma are very limited. Even with a multi-modal approach combining surgical resection, ...

Bayer BAYRY announced that the FDA has accepted its supplemental new drug application (sNDA) for Nubeqa (darolutamide). The ...

Should patients with TNBC who did not receive immunotherapy before surgery get it after, if they have residual disease?

The POLAR genomic signature can help predict the patients with early breast cancer who may benefit from adjuvant radiotherapy ...

Throughout 2024, the FDA issued new drug approvals and expanded treatment indications across various rheumatologic diseases.

Lung12, patients will be screened with the GRAIL assay prior to surgery to inform eligibility for post-surgery randomization to an adjuvant treatment regimen ( NCT06564844 ). Assay performance was ...

Platinum-based antineoplastic drugs are widely used in the treatment of solid tumors. Carboplatin is a safe and efficacious adjuvant treatment for stage I seminoma following a risk-adapted treatment ...

The 22nd Annual Winter Lung Cancer Conference® will explore advances in neoadjuvant/adjuvant therapies. The FDA has approved Obe-cel for R/R B-ALL, and new treatments in SCLC, lurbinectedin and ...

Oxford, UK-based rare respiratory diseases focused AlveoGene today revealed it has been granted a Rare Pediatric Disease ...

The field of drug delivery systems is witnessing significant advancements, particularly in the context of cancer treatment. Traditional chemotherapeutics, while potent, often suffer from nonspecific ...